Friday, October 16, 2026

AI Ethics Researchers Challenge 'AI for Good' as Corporate PR Strategy

Researchers Timnit Gebru and Abeba Birhane are reframing AI ethics from corporate 'AI for Good' narratives to systemic critiques of Big Tech's data practices, environmental costs, and labor exploitation. The AI Now Institute's Reframing Impact series documents how corporate AI rhetoric deflects criticism while encoding existing power structures. Critics warn African governments are adopting AI development models without assessing impacts on freedoms and knowledge systems.

AI Ethics Researchers Challenge 'AI for Good' as Corporate PR Strategy
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

AI ethics researchers are shifting focus from corporate social responsibility narratives to systemic critiques of how AI development concentrates power and resources. The AI Now Institute's Reframing Impact series features researchers like Timnit Gebru and Abeba Birhane challenging what they call the 'AI for Good' PR strategy.

"It's a way to paint a positive image of AI technologies, especially in light of the backlash from grassroots resistance movements," Birhane told AI Now Institute. "'AI for Good' allows companies to say 'Look, we're doing something good! You can't criticize us.'"

Gebru argues the dominant AI paradigm involves "stealing data, killing the environment, exploiting labor" as companies pursue what she calls building a "machine god." The critique extends beyond individual company practices to question the resource concentration behind large language models.

Investors pressure smaller language AI organizations to shut down when Big Tech announces models covering the same languages, Gebru reported. "When OpenAI or Meta comes with an announcement of a big model, potential investors literally told them to close up shop," she said.

Birhane warns that AI deployment may bring "surface-level improvements but also underlying destruction and division." She predicts AI systems will take time to reveal their full social impact, "encoding existing norms and stereotypes in a way that makes the rich richer and more powerful."

The researchers express particular concern about African governments adopting AI development rhetoric. "It's sometimes really scary the way you see some African governments jumping on the AI bandwagon and buying into this rhetoric that AI is going to 'leapfrog' the continent into prosperity," Birhane said. She notes "very little thought" goes to impacts on freedom of movement, speech, and knowledge ecosystems.

The Reframing Impact series represents a broader shift in AI ethics research from asking how to make AI systems fairer to questioning whether current development models should continue at all. The critique challenges assumptions that AI progress inevitably benefits society, demanding accountability for environmental, social, and labor costs.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]News articleAI Now Institute
    AI for Good
  2. [2]News articleAI Now Institute
    Frugal AI
  3. [3]News articleAI Now Institute
    Accountability
  4. [4]News articleAI Now Institute
    Democratization
  5. [5]News articleIEEE Spectrum
    How Do You Define an AI Companion?
  6. [6]News articleAI Now Institute
    Human Capital
  7. [7]News articleAI Now Institute
    Linguistic Diversity
  8. [8]News articleAI Now Institute
    Multilateralism
  9. [9]News articleAI Now Institute
    Open Source
  10. [10]News articleMIT Technology Review
    The Download: autonomous narco submarines, and virtue signaling chatbots
  11. [11]News articleMIT Technology Review
    The Download: unraveling a death threat mystery, and AI voice recreation for musicians
  12. [12]News articleMIT Technology Review
    The robots who predict the future

In this story

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com